Cargando…
Spotlight on Accessory Proteins: RTK-RAS-MAPK Modulators as New Therapeutic Targets
The RTK-RAS-MAPK axis is one of the most extensively studied signaling cascades and is related to the development of both cancers and RASopathies. In the last 30 years, many ideas and approaches have emerged for directly targeting constituent members of this cascade, predominantly in the context of...
Autores principales: | Pudewell, Silke, Ahmadian, Mohammad Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234298/ https://www.ncbi.nlm.nih.gov/pubmed/34208655 http://dx.doi.org/10.3390/biom11060895 |
Ejemplares similares
-
Accessory proteins of the RAS-MAPK pathway: moving from the side line to the front line
por: Pudewell, Silke, et al.
Publicado: (2021) -
New mechanistic insights into the RAS-SIN1 interaction at the membrane
por: Pudewell, Silke, et al.
Publicado: (2022) -
Tumorigenicity of RTK/RAS in urothelium
por: Wu, Xue-Ru, et al.
Publicado: (2015) -
RTK-RAS pathway mutation is enriched in myeloid sarcoma
por: Choi, Mihong, et al.
Publicado: (2018) -
Pancreatic Adenocarcinoma Therapeutics Targeting RTK and TGF Beta Receptor
por: Yang, Hsin-Han, et al.
Publicado: (2021)